These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29688754)

  • 1. Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study.
    Kim HW; Park EJ; Kim JH; Boon-Yasidhi V; Tarugsa J; Reyes A; Manalo S; Joung YS
    J Child Adolesc Psychopharmacol; 2018; 28(6):402-408. PubMed ID: 29688754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Corey-Lisle PK; Aman MG
    J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):229-36. PubMed ID: 21663425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Improvement and Safety of Aripiprazole for Irritability and Adaptive Function in Asian Children and Adolescents with Autistic Disorder: A 52-Week, Multinational, Multicenter, Open-Label Study.
    Kim BU; Kim HW; Park EJ; Kim JH; Boon-Yasidhi V; Tarugsa J; Reyes A; Manalo SG; Joung YS
    J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):390-399. PubMed ID: 36112116
    [No Abstract]   [Full Text] [Related]  

  • 4. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder.
    Owen R; Sikich L; Marcus RN; Corey-Lisle P; Manos G; McQuade RD; Carson WH; Findling RL
    Pediatrics; 2009 Dec; 124(6):1533-40. PubMed ID: 19948625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.
    Marcus RN; Owen R; Kamen L; Manos G; McQuade RD; Carson WH; Aman MG
    J Am Acad Child Adolesc Psychiatry; 2009 Nov; 48(11):1110-1119. PubMed ID: 19797985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of aripiprazole for irritability in pediatric patients with autistic disorder: a 52-week, open-label, multicenter study.
    Marcus RN; Owen R; Manos G; Mankoski R; Kamen L; McQuade RD; Carson WH; Findling RL
    J Clin Psychiatry; 2011 Sep; 72(9):1270-6. PubMed ID: 21813076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder.
    Aman MG; Kasper W; Manos G; Mathew S; Marcus R; Owen R; Mankoski R
    J Child Adolesc Psychopharmacol; 2010 Oct; 20(5):415-22. PubMed ID: 20973712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open-label extension long-term study of the safety and efficacy of aripiprazole for irritability in children and adolescents with autistic disorder in Japan.
    Ichikawa H; Hiratani M; Yasuhara A; Tsujii N; Oshimo T; Ono H; Tadori Y
    Psychiatry Clin Neurosci; 2018 Feb; 72(2):84-94. PubMed ID: 28941259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.
    Findling RL; Mankoski R; Timko K; Lears K; McCartney T; McQuade RD; Eudicone JM; Amatniek J; Marcus RN; Sheehan JJ
    J Clin Psychiatry; 2014 Jan; 75(1):22-30. PubMed ID: 24502859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aripiprazole in the Treatment of Irritability in Children and Adolescents with Autism Spectrum Disorder in Japan: A Randomized, Double-blind, Placebo-controlled Study.
    Ichikawa H; Mikami K; Okada T; Yamashita Y; Ishizaki Y; Tomoda A; Ono H; Usuki C; Tadori Y
    Child Psychiatry Hum Dev; 2017 Oct; 48(5):796-806. PubMed ID: 28004215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole treatment of irritability associated with autistic disorder and the relationship between prior antipsychotic exposure, adverse events, and weight change.
    Mankoski R; Stockton G; Manos G; Marler S; McQuade R; Forbes RA; Marcus R
    J Child Adolesc Psychopharmacol; 2013 Oct; 23(8):572-6. PubMed ID: 24138011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.
    Curran MP
    Paediatr Drugs; 2011 Jun; 13(3):197-204. PubMed ID: 21500873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of aripiprazole 2 to 15 mg/d on health-related quality of life in the treatment of irritability associated with autistic disorder in children: a post hoc analysis of two controlled trials.
    Varni JW; Handen BL; Corey-Lisle PK; Guo Z; Manos G; Ammerman DK; Marcus RN; Owen R; McQuade RD; Carson WH; Mathew S; Mankoski R
    Clin Ther; 2012 Apr; 34(4):980-92. PubMed ID: 22444782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paliperidone for irritability in adolescents and young adults with autistic disorder.
    Stigler KA; Mullett JE; Erickson CA; Posey DJ; McDougle CJ
    Psychopharmacology (Berl); 2012 Sep; 223(2):237-45. PubMed ID: 22549762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yokukansan (TJ-54) for irritability associated with pervasive developmental disorder in children and adolescents: a 12-week prospective, open-label study.
    Wake R; Miyaoka T; Inagaki T; Furuya M; Ieda M; Liaury K; Kishi K; Horiguchi J
    J Child Adolesc Psychopharmacol; 2013 Jun; 23(5):329-36. PubMed ID: 23782127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole in the real-world treatment for irritability associated with autism spectrum disorder in children and adolescents in Japan: 52-week post-marketing surveillance.
    Sugimoto Y; Yamamura K; Takayama T; Fukuta Y; Aoki K; Mikami K; Tomoda A
    BMC Psychiatry; 2021 Apr; 21(1):204. PubMed ID: 33888067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. l-Carnosine As an Adjunctive Therapy to Risperidone in Children with Autistic Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Hajizadeh-Zaker R; Ghajar A; Mesgarpour B; Afarideh M; Mohammadi MR; Akhondzadeh S
    J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):74-81. PubMed ID: 29027815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study.
    Pan PY; Fu AT; Yeh CB
    J Child Adolesc Psychopharmacol; 2018 Dec; 28(10):682-689. PubMed ID: 30148656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ; Lane R; Nuamah I; Gopal S; Hough D
    J Am Acad Child Adolesc Psychiatry; 2015 Feb; 54(2):126-137.e1. PubMed ID: 25617253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.